146 related articles for article (PubMed ID: 20798777)
21. Removal of urea by electro-oxidation in a miniature dialysis device: a study in awake goats.
Wester M; van Gelder MK; Joles JA; Simonis F; Hazenbrink DHM; van Berkel TWM; Vaessen KRD; Boer WH; Verhaar MC; Gerritsen KGF
Am J Physiol Renal Physiol; 2018 Nov; 315(5):F1385-F1397. PubMed ID: 29993277
[TBL] [Abstract][Full Text] [Related]
22. The removal of uremic small and middle molecules and free amino acids by carbon hemoperfusion.
Oulès R; Asaba H; Neuhäuser M; Yahiel V; Gunnarsson B; Bergström J; Fürst P
Trans Am Soc Artif Intern Organs; 1977; 23():583-90. PubMed ID: 910385
[No Abstract] [Full Text] [Related]
23. [Study on cytomedicine of alginate-poly(L) lysine-alginate microencapsulated hybridoma cells].
Zhao DJ; Jin Y; Fu HX; Chen P
Yao Xue Xue Bao; 2004 Aug; 39(8):635-9. PubMed ID: 15563068
[TBL] [Abstract][Full Text] [Related]
24. Growth and survival of renal failure rats that received oral microencapsulated genetically engineered E. coli DH5 cells for urea removal.
Prakash S; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1998 Jan; 26(1):35-51. PubMed ID: 9507755
[TBL] [Abstract][Full Text] [Related]
25. Microencapsulated genetically engineered E. coli DH5 cells for plasma urea and ammonia removal based on: 1. Column bioreactor and 2. Oral administration in uremic rats.
Prakash S; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1996 May; 24(3):201-18. PubMed ID: 8773740
[TBL] [Abstract][Full Text] [Related]
26. Preparation and microscopy examination of alginate-poly-L-lysine-alginate microcapsules.
Fu HX; Li H; Wu LL; Zhao YZ; Xu YY; Zhu YL; Xue SL; Wang DW; Liu CY; Yang SL; Li XK
Drug Dev Ind Pharm; 2014 Nov; 40(11):1523-9. PubMed ID: 24564824
[TBL] [Abstract][Full Text] [Related]
27. Response to rapid removal of intermediate molecular weight solutes in uremic man.
Silverstein ME; Ford CA; Lysaght MJ; Henderson LW
Trans Am Soc Artif Intern Organs; 1974; 20 B():614-21. PubMed ID: 4450311
[No Abstract] [Full Text] [Related]
28. Are the classical markers sufficient to describe uremic solute accumulation in dialyzed patients? Hippurates reconsidered.
Schoots AC; Dijkstra JB; Ringoir SM; Vanholder R; Cramers CA
Clin Chem; 1988 Jun; 34(6):1022-9. PubMed ID: 3378319
[TBL] [Abstract][Full Text] [Related]
29. Effects of pregnancy on the development of acute uremic syndrome in the rat.
Nitzan M; Klipper-Orbach J
Isr J Med Sci; 1976 Feb; 12(2):129-33. PubMed ID: 4412
[TBL] [Abstract][Full Text] [Related]
30. Chronic nitric oxide inhibition aggravates hypertension in erythropoietin-treated renal failure rats.
Moreau C; Larivière R; Kingma I; Grose JH; Lebel M
Clin Exp Hypertens; 2000; 22(7-8):663-74. PubMed ID: 11131043
[TBL] [Abstract][Full Text] [Related]
31. Correcting acidosis in hemodialysis: effect on phosphate clearance and calcification risk.
Harris DC; Yuill E; Chesher DW
J Am Soc Nephrol; 1995 Dec; 6(6):1607-12. PubMed ID: 8749687
[TBL] [Abstract][Full Text] [Related]
32. Changes in the electroencephalogram in acute uremia. Effects of parathyroid hormone and brain electrolytes.
Guisado R; Arieff AI; Massry SG; Lazarowitz V; Kerian A
J Clin Invest; 1975 Apr; 55(4):738-45. PubMed ID: 235562
[TBL] [Abstract][Full Text] [Related]
33. Effects of intravenous nutrition on lipoprotein metabolism, body composition, weight gain and uremic state in experimental uremia in rats.
Wennberg A; Norbeck HE; Sterner G; Lundholm K
J Nutr; 1991 Sep; 121(9):1439-46. PubMed ID: 1908894
[TBL] [Abstract][Full Text] [Related]
34. Changes in insulin binding during hemodialysis in uremic patients.
Milutinović S; Breyer D; Molnar V; Stefović A; Janković N; Skrabalo Z; Rocić B
Nephron; 1985; 41(4):307-13. PubMed ID: 3906417
[TBL] [Abstract][Full Text] [Related]
35. An orally delivered microbial cocktail for the removal of nitrogenous metabolic waste in animal models of kidney failure.
Zheng DW; Pan P; Chen KW; Fan JX; Li CX; Cheng H; Zhang XZ
Nat Biomed Eng; 2020 Sep; 4(9):853-862. PubMed ID: 32632226
[TBL] [Abstract][Full Text] [Related]
36. An orally administered microcapsule system for treating chronic renal failure patients.
Gardner DL; Kjellstrand CM; Hassler CR; Fink DJ; Emmerling DC
Appl Biochem Biotechnol; 1984; 10():27-40. PubMed ID: 6524933
[TBL] [Abstract][Full Text] [Related]
37. Morphological evaluation of the lungs in rats with experimentally induced renal failure.
Kasacka I; Piłat-Marcinkiewicz B; Pankiewicz W; Sulewska A
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():204-6. PubMed ID: 15638424
[TBL] [Abstract][Full Text] [Related]
38. Are urea and creatinine uremic toxins in the rat?
Levine S; Saltzman A
Ren Fail; 2001 Jan; 23(1):53-9. PubMed ID: 11256529
[TBL] [Abstract][Full Text] [Related]
39. Live E. coli cells to treat uremia.
Wrong O
Nat Med; 1997 Jan; 3(1):3; author reply 3-4. PubMed ID: 8986726
[No Abstract] [Full Text] [Related]
40. Serum middle molecule levels in uremia during long term intermittent hemoperfusions with the acac (coated charcoal) microcapsule artificial kidney.
Chang TM; Migchelsen M; Coffey JF; Stark A
Trans Am Soc Artif Intern Organs; 1974; 20A():364-71. PubMed ID: 4217485
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
